The Association of Vacuum-Assisted Closure Therapy with Dynamic Volume Change of a Muscle Flap Transposed in an Empyema Cavity for Chronic Empyema: A Case Report.

The Association of Vacuum-Assisted Closure Therapy with Dynamic Volume Change of a Muscle Flap Transposed in an Empyema Cavity for Chronic Empyema: A Case Report. Ann Thorac Cardiovasc Surg. 2020 Jan 29;: Authors: Kojima K, Sakamoto T, Sakurai T, Yagi Y, Utsumi T, Yoon H Abstract A 62-year-old woman with a history of lung resection for lung cancer was admitted to our hospital due to cough, which became progressively more severe. She was diagnosed with chronic empyema with bronchopleural fistula (BPF) of the right upper bronchial stump. Although a pedicled muscle flap was transposed to the empyema cavity, the fistula remained. We used a vacuum-assisted closure system after open-window thoracotomy and observed the cavity reduction with expansion of the transposed muscle flap. We quantitatively evaluated the dynamics of the cavity change using a three-dimensional image analysis system. A reduction of the volume of the muscle flap by prolonged empyema and expansion of the muscle flap was observed immediately after vacuum-assisted management. However, expansion of the right residual lung was not recognized. Pedicled muscle flap transposition followed by vacuum-assisted management after open-window thoracotomy may be effective for treating chronic empyema caused by BPF. PMID: 31996507 [PubMed - as supplied by publisher]
Source: Annals of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Cardiovasc Surg Source Type: research

Related Links:

Tuesday, March 10. Speech-language pathologist Fatima Warren was grocery shopping with her grandmother when she first noticed the painful body aches. Chalking it up to the rainy day and an earlier workout, she ran a hot bath. Wednesday, March 11. Warren woke up with chills, fever, and worsening aches. She drove straight to the closest ER in her hometown of Lexington, Kentucky. There, staff ran numerous tests, but not for COVID-19. The 45-year-old didn’t qualify because she hadn’t traveled outside the country and couldn’t name a contact with the virus. Thursday, March 12. Worried about infecting her 13-yea...
Source: American Speech-Language-Hearing Association (ASHA) Press Releases - Category: Speech-Language Pathology Authors: Tags: Slider Speech-Language Pathology Uncategorized acute care Cognitive Rehabilitation Dysphagia FEES Health Care MBSS personal protective equipment skilled nursing facilities Swallowing Disorders Source Type: blogs
Dr. Laura Mulvey, 33, practices emergency medicine at Maimonides Medical Center in Brooklyn, New York. After spending six days receiving treatment in her own hospital, she is now recovering at home from what is presumed to be COVID-19, though her test was inconclusive. What follows is a lightly-edited transcript of her story as told to TIME. Early on, sometime in February, [COVID-19] was something that people were thinking about. And worried about. Certainly, the worries were not what they are now. But hospital-wise, we had a bit of an earlier jump on it, because we recognized that this was a potential threat. We’re ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news
Abstract Erythroderma as the first manifestation of a solid organ malignancy is rare. The underlying cancer is a challenging condition to diagnose. There are a few cases of erythroderma in cancer patients reported in the literature. We here describe the case of a 70-year-old man who presented with asthenia, weight loss, dry cough and total body erythema with desquamation over the past month. A chest computed tomography scan showed a nodular lesion, which was finally diagnosed as a squamous cell lung carcinoma. To our knowledge, as an erythroderma presentation, only 13 cases have been reported in the literature. This case r...
Source: Anais Brasileiros de Dermatologia - Category: Dermatology Source Type: research
LUNG cancer can reveal itself with a recurring cough. But with the coronavirus outbreak taking centre stage and the winter months notorious for the common cold and flu, how do you know what your cough is actually a sign of?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Basel, 3 March 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Esbriet ® (pirfenidone) for adults with unclassifiable interstitial lung disease (uILD). The designation was granted based on data from a Phase II trial, which studied the efficacy and safety of Esbriet in uILD[1]. The study represented the first randomised controlled trial to exclusively enroll patients with progressive fibrosing uILD.“Today’s milestone for Esbriet builds on our continued commitment to improving the standard of care ...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
LUNG cancer begins when cells inside the lungs start to reproduce at an uncontrollable rate, eventually forming a cancerous tumour. What's the revealing symptom you could have the deadly disease, particularly when you cough in a tissue?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
ConclusionIn lung cancer patients undergoing thoracotomy, three to five tDCS sessions significantly reduced cumulative postoperative morphine use, maximum VAS pain scores with cough, and pain interference with cough on postoperative day 5, but there was no obvious long-term benefit from tDCS.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
ConclusionsClinicians should be aware of this unique form of recurrence in patients with large cell neuroendocrine carcinoma of the lungs.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Findings based on analysis of index symptoms of U.K. patients from 2000 to 2017
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Emergency Medicine, Nursing, Oncology, Pulmonology, Journal, Source Type: news
In conclusion, early intensive nutrition intervention with oral supplements of Texidrofolico® during chemotherapy of NSCLC patients prevents weight loss and it is beneficial for their quality of life. PMID: 32034492 [PubMed - as supplied by publisher]
Source: Amino Acids - Category: Biochemistry Authors: Tags: Amino Acids Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cough | Heart | Hospitals | Japan Health | Lung Cancer | Science | Thoracotomy